Potential pitfalls of TAVI in low risk patients

Summary

Will TAVI be indicated for lower risk patients in 10 years? Join M. Gilard and B. Prendergast as they discuss the implications of enlarging TAVI beginning with the question of whether conventional risk scores used in clinical trials effectively translate into everyday clinical practice. What part will be played by the treatment of bicuspid valves in this lower-risk population? What are the concerns about stroke and the use of protection devices, their evolution and their cost? Or pacemakers? These, and other questions such as the treatment of coronary artery disease in this population are touched on in this fascinating discussion…